DE60124587D1 - 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung - Google Patents

2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung

Info

Publication number
DE60124587D1
DE60124587D1 DE60124587T DE60124587T DE60124587D1 DE 60124587 D1 DE60124587 D1 DE 60124587D1 DE 60124587 T DE60124587 T DE 60124587T DE 60124587 T DE60124587 T DE 60124587T DE 60124587 D1 DE60124587 D1 DE 60124587D1
Authority
DE
Germany
Prior art keywords
propoxyen
nitrobenzofurane
dibutylamino
benzoyl
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60124587T
Other languages
English (en)
Other versions
DE60124587T2 (de
Inventor
Michel Biard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60124587D1 publication Critical patent/DE60124587D1/de
Publication of DE60124587T2 publication Critical patent/DE60124587T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60124587T 2000-12-11 2001-12-10 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung Expired - Lifetime DE60124587T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0016069A FR2817865B1 (fr) 2000-12-11 2000-12-11 Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
FR0016069 2000-12-11
PCT/FR2001/003900 WO2002048078A1 (fr) 2000-12-11 2001-12-10 Chlorhydrate du 2-butyl-3-(4-'3-(dibutylamino)propoxy!benzoyl)-5-nitro-benzofurane et sa preparation

Publications (2)

Publication Number Publication Date
DE60124587D1 true DE60124587D1 (de) 2006-12-28
DE60124587T2 DE60124587T2 (de) 2007-09-20

Family

ID=8857481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124587T Expired - Lifetime DE60124587T2 (de) 2000-12-11 2001-12-10 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung

Country Status (21)

Country Link
US (1) US6846936B2 (de)
EP (1) EP1351907B1 (de)
JP (2) JP4437004B2 (de)
CN (2) CN1295200C (de)
AR (1) AR035663A1 (de)
AT (1) ATE345319T1 (de)
AU (1) AU2002217227A1 (de)
BR (1) BR0116065B1 (de)
CA (1) CA2429268C (de)
CZ (1) CZ303489B6 (de)
DE (1) DE60124587T2 (de)
DK (1) DK1351907T3 (de)
ES (1) ES2276741T3 (de)
FR (1) FR2817865B1 (de)
HK (1) HK1055944A1 (de)
HR (1) HRP20030471B1 (de)
HU (1) HUP0500981A3 (de)
MX (1) MXPA03005223A (de)
PL (1) PL206029B1 (de)
SK (1) SK287770B6 (de)
WO (1) WO2002048078A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the
GB0719180D0 (en) * 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
US8410167B2 (en) * 2008-04-17 2013-04-02 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (de) * 2008-04-29 2009-11-11 Sanofi-Aventis Verfahren zur Verwaltung von Risiken in Zusammenhang mit der Zunahme von Serumkreatinin bei der Dronedaron-Behandlung
EP2246341A1 (de) 2009-01-23 2010-11-03 Lonza Ltd. Verfahren zur Herstellung von 2-Alkyl-3-aroyl-5-nitro-benzofuranen
EP2417099B1 (de) * 2009-04-08 2015-12-23 Cambrex Karlskoga AB Neues verfahren zur herstellung von hydroxylaminen und medikamenten
TW201111354A (en) 2009-05-27 2011-04-01 Sanofi Aventis Process for the production of Dronedarone intermediates
TW201107303A (en) 2009-05-27 2011-03-01 Sanofi Aventis Process for the production of benzofurans
CN101993427B (zh) * 2009-08-26 2012-10-10 成都伊诺达博医药科技有限公司 一种制备决奈达隆的方法
HUP0900759A2 (en) 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
IT1398317B1 (it) * 2010-02-23 2013-02-22 Chimico Internaz Spa Lab Nuovo procedimento per la preparazione del dronedarone.
FR2957079B1 (fr) 2010-03-02 2012-07-27 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
EP2371824A1 (de) * 2010-03-08 2011-10-05 Ratiopharm GmbH Kristalline Dronedaronsalze
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
FR2958291B1 (fr) 2010-04-01 2013-07-05 Sanofi Aventis Procede de preparation de derives d'amino-benzofurane
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2012004658A2 (en) * 2010-07-09 2012-01-12 Frichem Private Limited Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof
WO2012007959A1 (en) * 2010-07-16 2012-01-19 Glenmark Generics Limited Process for preparing dronedarone
FR2962731B1 (fr) 2010-07-19 2012-08-17 Sanofi Aventis Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2963006B1 (fr) 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
WO2012032545A1 (en) 2010-09-08 2012-03-15 Cadila Healthcare Limited Processes for preparing dronedarone and its intermediates
EP2447256A1 (de) * 2010-10-21 2012-05-02 Laboratorios Lesvi, S.L. Verfahren zur Gewinnung von Dronedaron
CN102070578B (zh) * 2011-01-19 2015-10-14 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-烷酰基氨基苯并呋喃的制备方法
CN102070580B (zh) * 2011-01-19 2015-05-20 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-取代氨基苯并呋喃的制备
CN102070581B (zh) * 2011-01-19 2015-11-25 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-氨基苯并呋喃的制备
CN102070579B (zh) * 2011-01-19 2016-03-09 上海医药工业研究院 2-正丁基-3-(4-取代丙氧基苯甲酰基)-5-取代氨基苯并呋喃的制备方法
WO2012120544A2 (en) 2011-03-10 2012-09-13 Sun Pharmaceutical Industries Ltd. PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE
CN102690249B (zh) * 2011-03-22 2014-09-17 江苏康缘药业股份有限公司 一种决奈达隆的制备方法
HUP1100166A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Reductive amination process for preparation of dronedarone using amine intermediary compound
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
WO2013014480A1 (en) 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
WO2013014479A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive animation process for preparation of dronedarone using aldehyde intermediary compound
WO2013014478A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive amination process for preparation of dronedarone using carboxyl intermediary compound
ITMI20111672A1 (it) * 2011-09-16 2013-03-17 Olon Spa Metodo efficiente per la preparazione di dronedarone cloridrato
FR2983198B1 (fr) * 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (de) 2012-01-20 2013-07-24 Sanofi Verfahren zur Herstellung von Dronedaron unter Verwendung von Dibutylaminopropanolreagenz
WO2013121235A2 (en) 2012-02-13 2013-08-22 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
US9382223B2 (en) 2012-02-22 2016-07-05 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) * 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction
CN102675267B (zh) * 2012-06-07 2015-05-13 济南富创医药科技有限公司 盐酸决奈达隆及其中间体的制备方法
CN108164411B (zh) * 2017-12-29 2021-03-02 苏州汶颢微流控技术股份有限公司 基于微反应器制备对庚氧基苯甲酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4024273A (en) * 1974-06-20 1977-05-17 Smithkline Corporation Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
CN100371314C (zh) 2008-02-27
WO2002048078A1 (fr) 2002-06-20
BR0116065A (pt) 2003-10-28
US20040010032A1 (en) 2004-01-15
HRP20030471A2 (en) 2004-08-31
CN1479706A (zh) 2004-03-03
CN1295200C (zh) 2007-01-17
AR035663A1 (es) 2004-06-23
EP1351907B1 (de) 2006-11-15
ATE345319T1 (de) 2006-12-15
ES2276741T3 (es) 2007-07-01
SK287770B6 (sk) 2011-09-05
SK7272003A3 (en) 2003-11-04
EP1351907A1 (de) 2003-10-15
PL364774A1 (en) 2004-12-13
CA2429268A1 (fr) 2002-06-20
HRP20030471B1 (en) 2011-07-31
FR2817865A1 (fr) 2002-06-14
CZ20031611A3 (cs) 2003-08-13
MXPA03005223A (es) 2004-04-20
HUP0500981A3 (en) 2012-09-28
DE60124587T2 (de) 2007-09-20
AU2002217227A1 (en) 2002-06-24
JP4437004B2 (ja) 2010-03-24
US6846936B2 (en) 2005-01-25
CN1769262A (zh) 2006-05-10
FR2817865B1 (fr) 2005-02-18
HK1055944A1 (en) 2004-01-30
CA2429268C (fr) 2011-02-01
CZ303489B6 (cs) 2012-10-17
JP2004515536A (ja) 2004-05-27
DK1351907T3 (da) 2007-03-26
JP2009024007A (ja) 2009-02-05
PL206029B1 (pl) 2010-06-30
HUP0500981A2 (en) 2006-03-28
BR0116065B1 (pt) 2014-03-25

Similar Documents

Publication Publication Date Title
DE60124587D1 (de) 2-butyl-3-(4-3(dibutylamino)propoxyü benzoyl)-5-nitrobenzofuran-hydrochlorid und dessen herstellung
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
DE50106776D1 (de) Anzeigeinstrument
NO20024906L (no) Antitumorale ecteinascidinderivater
EE05020B1 (et) Glburiidi ravimkoostis
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
DE50113956D1 (de) Anzeigeinstrument
DE60125981D1 (de) Amlodipin in form der freien base
DE60135797D1 (de) Kunstleder
ATE505459T1 (de) Dibenzoäb,füazepin-derivate und ihre herstellung
DE50113112D1 (de) Schaltungsanordnung
DE60100576D1 (de) Messuhr
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
NO20023534L (no) Stolunderstell
DE60118970D1 (de) Indol- und dihydroindolderivate
ATE295687T1 (de) Gegen pflanzenkrankheiten verwendbare pseudomycine
DE50115426D1 (de) Schaltungsanordnung
EE00224U1 (et) Vundament
ES1047611Y (es) Taburete
UA3100S (uk) Стійка під гантелі

Legal Events

Date Code Title Description
8364 No opposition during term of opposition